Calpine Corp (CPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2002 | 09-2002 | 06-2002 | 03-2002 | 12-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 756,202 | 659,694 | 528,767 | 410,772 | 1,696,777 |
| Receivables | 745,312 | 838,632 | 1,009,552 | 817,936 | 966,707 |
| Inventories | 105,872 | 104,813 | 96,662 | 90,627 | 82,801 |
| Other current assets | 476,231 | 873,921 | 811,891 | 682,211 | 925,517 |
| TOTAL | $2,236,030 | $2,677,096 | $2,691,326 | $2,306,110 | $4,123,176 |
| Non-Current Assets | |||||
| PPE Net | 18,730,850 | 17,483,400 | 17,118,310 | 16,211,490 | 15,327,390 |
| Investments And Advances | 421,402 | 428,610 | 431,046 | 380,558 | 392,711 |
| Intangibles | 122,231 | 0 | 0 | 0 | 138,665 |
| Other Non-Current Assets | 1,716,482 | 2,100,220 | 1,989,058 | 1,745,378 | 1,955,281 |
| TOTAL | $20,990,965 | $20,012,230 | $19,538,414 | $18,337,426 | $17,814,047 |
| Total Assets | $23,226,990 | $22,689,330 | $22,229,740 | $20,643,540 | $21,937,230 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,647,994 | 417,898 | 157,886 | 699,836 | 901,238 |
| Accounts payable and accrued liabilities | 1,237,261 | 1,117,801 | 1,250,424 | 1,260,579 | 1,286,699 |
| Accrued Expenses | 189,336 | 202,947 | 186,302 | 194,538 | 185,727 |
| TOTAL | $3,567,131 | $2,435,159 | $2,322,305 | $2,889,009 | $3,251,554 |
| Non-Current Liabilities | |||||
| Long Term Debt | 11,064,640 | 11,602,790 | 11,597,440 | 10,473,610 | 11,191,710 |
| Other Non-Current Liabilities | 3,213,227 | 3,190,630 | 3,039,614 | 2,958,176 | 3,226,057 |
| TOTAL | $15,807,950 | $16,332,930 | $16,039,570 | $14,796,660 | $15,717,540 |
| Total Liabilities | $19,375,080 | $18,768,090 | $18,361,880 | $17,685,660 | $18,969,100 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 381,168 | 377,999 | 376,700 | 373,912 | 307,602 |
| Common Shares | 381 | 378 | 376 | 308 | 307 |
| Retained earnings | 1,286,487 | 1,355,597 | 1,194,249 | 1,121,733 | 1,167,869 |
| Other shareholders' equity | -237,457 | -230,317 | -118,707 | -207,986 | -240,880 |
| TOTAL | $3,851,914 | $3,921,240 | $3,867,860 | $2,957,871 | $2,968,129 |
| Total Liabilities And Equity | $23,226,994 | $22,689,330 | $22,229,740 | $20,643,531 | $21,937,229 |